Dry eye disease as a common ocular disorder – current knowledge and management
DOI:
https://doi.org/10.12775/JEHS.2024.67.51099Keywords
Dry eye disease, Dry eye syndrome, blurred vision, treatment, artificial tearsAbstract
Introduction and purpose
Dry eye disease is one of the most common ocular surface diseases. It is a multifactorial disease that contributes to symptoms impairing daily functioning. Dry eye syndrome occurs in up to half of the population. Therefore, proper diagnosis and treatment are necessary.
The state of knowledge
One of the most common causes is meibomian gland dysfunction, which leads to impaired homeostasis and easy evaporation of tears. Environmental factors such as air pollution and stimulants also influence the occurrence of dry eye syndrome. All these factors lead to bothersome symptoms such as impaired visual acuity, itching, pain or burning. Patients also complain of a feeling of sand under the eyelids or photophobia. These patients' diagnoses are based mainly on history and ophthalmologic examination. Also, the Schirmer test or fluorescein staining can be used. It is essential to quickly apply treatment, which is mainly based on Artificial tears. Artificial tears are primarily a symptomatic treatment, while they are first-line therapy. In addition, treatment can include serum drops, anti-inflammatory drugs, or supplementation with omega-3 and omega-6 acids.
Summary
Dry eye disease affects many people, especially the elderly. Symptoms may impair normal functioning. Untreated dry eye syndrome can also lead to many complications. Therefore, a proper diagnosis, primarily based on a basic ophthalmological examination, and individually tailored treatment are necessary. New treatment methods are described in the literature, and they seem to be promising.
References
Huang, R., C. Su, L. Fang, et al., Dry eye syndrome: comprehensive etiologies and recent clinical trials. Int Ophthalmol, 2022. 42(10): p. 3253-3272.
Tsubota, K., S.C. Pflugfelder, Z. Liu, et al., Defining Dry Eye from a Clinical Perspective. Int J Mol Sci, 2020. 21(23).
Craig, J.P., K.K. Nichols, E.K. Akpek, et al., TFOS DEWS II Definition and Classification Report. Ocul Surf, 2017. 15(3): p. 276-283.
Stapleton, F., M. Alves, V.Y. Bunya, et al., TFOS DEWS II Epidemiology Report. Ocul Surf, 2017. 15(3): p. 334-365.
O'Neil, E.C., M. Henderson, M. Massaro-Giordano, et al., Advances in dry eye disease treatment. Curr Opin Ophthalmol, 2019. 30(3): p. 166-178.
Sheppard, J., B. Shen Lee, and L.M. Periman, Dry eye disease: identification and therapeutic strategies for primary care clinicians and clinical specialists. Ann Med, 2023. 55(1): p. 241-252.
Moss, S.E., R. Klein, and B.E. Klein, Prevalence of and risk factors for dry eye syndrome. Arch Ophthalmol, 2000. 118(9): p. 1264-8.
DYBAŁA, E., DYBAŁA-PRZYGRODZKA, Izabela, AGHADI, Artur, CUBER, Iwona, BIAŁOWĄS, Edyta and MAZUREK, Magdalena., Dry eye syndrome - vicious circle mechanism of disease. Journal of Education, Health and Sport. Online, 6 February 2023. Vol. 13, no. 3: p. 207-216.
Moon, J., C.H. Yoon, S.H. Choi, et al., Can Gut Microbiota Affect Dry Eye Syndrome? Int J Mol Sci, 2020. 21(22).
The definition and classification of dry eye disease: report of the Definition and Classification Subcommittee of the International Dry Eye WorkShop (2007). Ocul Surf, 2007. 5(2): p. 75-92.
Bron, A.J., C.S. de Paiva, S.K. Chauhan, et al., TFOS DEWS II pathophysiology report. Ocul Surf, 2017. 15(3): p. 438-510.
Chan, T.C.Y., S.S.W. Chow, K.H.N. Wan, et al., Update on the association between dry eye disease and meibomian gland dysfunction. Hong Kong Med J, 2019. 25(1): p. 38-47.
Mittal, R., S. Patel, and A. Galor, Alternative therapies for dry eye disease. Curr Opin Ophthalmol, 2021. 32(4): p. 348-361.
Stern, M.E. and S.C. Pflugfelder, Inflammation in dry eye. Ocul Surf, 2004. 2(2): p. 124-30.
Rolando, M. and S. Barabino, Dry Eye Disease: What Is the Role of Vitamin D? Int J Mol Sci, 2023. 24(2).
Savini, G., P. Prabhawasat, T. Kojima, et al., The challenge of dry eye diagnosis. Clin Ophthalmol, 2008. 2(1): p. 31-55.
Wolffsohn, J.S., R. Arita, R. Chalmers, et al., TFOS DEWS II Diagnostic Methodology report. Ocul Surf, 2017. 15(3): p. 539-574.
Jones, L., L.E. Downie, D. Korb, et al., TFOS DEWS II Management and Therapy Report. Ocul Surf, 2017. 15(3): p. 575-628.
Kawashima, M., K. Sano, S. Takechi, et al., Impact of lifestyle intervention on dry eye disease in office workers: a randomized controlled trial. J Occup Health, 2018. 60(4): p. 281-288.
Calonge, M., The Treatment of Dry Eye. Survey of Ophthalmology, 2001. 45: p. S227-S239.
Yang, Y.J., W.Y. Lee, Y.J. Kim, et al., A Meta-Analysis of the Efficacy of Hyaluronic Acid Eye Drops for the Treatment of Dry Eye Syndrome. Int J Environ Res Public Health, 2021. 18(5).
Narang, P., P.R. Donthineni, S. D'Souza, et al., Evaporative dry eye disease due to meibomian gland dysfunction: Preferred practice pattern guidelines for diagnosis and treatment. Indian J Ophthalmol, 2023. 71(4): p. 1348-1356.
Marshall, L.L. and J.M. Roach, Treatment of Dry Eye Disease. Consult Pharm, 2016. 31(2): p. 96-106.
Pan, Q., A. Angelina, M. Marrone, et al., Autologous serum eye drops for dry eye. Cochrane Database Syst Rev, 2017. 2(2): p. Cd009327.
Liu, Y., W.R. Kam, and D.A. Sullivan, Influence of Omega 3 and 6 Fatty Acids on Human Meibomian Gland Epithelial Cells. Cornea, 2016. 35(8): p. 1122-6.
Downie, L.E., S.M. Ng, K.B. Lindsley, et al., Omega-3 and omega-6 polyunsaturated fatty acids for dry eye disease. Cochrane Database Syst Rev, 2019. 12(12): p. Cd011016.
Barabino, S., J. Horwath-Winter, E.M. Messmer, et al., The role of systemic and topical fatty acids for dry eye treatment. Prog Retin Eye Res, 2017. 61: p. 23-34.
Kurtul, B.E., P.A. Özer, and M.S. Aydinli, The association of vitamin D deficiency with tear break-up time and Schirmer testing in non-Sjögren dry eye. Eye (Lond), 2015. 29(8): p. 1081-4.
Demirci, G., S. Karaman Erdur, M. Ozsutcu, et al., Dry Eye Assessment in Patients With Vitamin D Deficiency. Eye Contact Lens, 2018. 44 Suppl 1: p. S62-s65.
Prinz, J., N. Maffulli, M. Fuest, et al., Honey-Related Treatment Strategies in Dry Eye Disease. Pharmaceuticals (Basel), 2023. 16(5).
Chaudhary, S., D. Ghimire, S. Basu, et al., Contact lenses in dry eye disease and associated ocular surface disorders. Indian J Ophthalmol, 2023. 71(4): p. 1142-1153.
Uchino, M., Y. Uchino, M. Dogru, et al., Dry eye disease and work productivity loss in visual display users: the Osaka study. Am J Ophthalmol, 2014. 157(2): p. 294-300.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Barbara Rękas, Wojciech Mazurek, Monika Stradczuk, Łukasz Mazurek, Barbara Kruczyk, Mateusz Piętak, Marcelina Gniot
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The periodical offers access to content in the Open Access system under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0
Stats
Number of views and downloads: 213
Number of citations: 0